StockSelector.com
  Research, Select, & Monitor Friday, February 15, 2019 8:11:46 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ligand Pharmaceuticals, Inc.$120.86($.02)(.02%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ligand Pharmaceuticals, Inc. has an overall rank of 46 out of 5753 stocks based on 11 positive rankings and 7 negative rankings.

Positive Rankings
Highest Cash Growth
Ligand Pharmaceuticals rank is 5
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Ligand Pharmaceuticals is ranked 13.
Historic EPS Growth
Ligand Pharmaceuticals rank is 30
Highest Net Margin
Ligand Pharmaceuticals rank is 30
Positive Guidance
Within the past 90 days Ligand Pharmaceuticals has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Historic Revenue Growth
Ligand Pharmaceuticals rank is 61
Highest ROE
Ligand Pharmaceuticals rank is 198
Highest ROA
Ligand Pharmaceuticals rank is 210
Up EPS Surprise
Ligand Pharmaceuticals beat the consensus earnings estimate when it last reported quarterly earnings.
SSValue
The StockSelector Value for Ligand Pharmaceuticals is $278.84. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ligand Pharmaceuticals is ranked 436.
10 Day Gain
Ligand Pharmaceuticals rank is 1872
Negative Rankings
Price-to-Sales
Ligand Pharmaceuticals rank is 111
High Put/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 3.51 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 177.
High vPut/Call
Ligand Pharmaceuticals has a high Put/Call ratio of 4.78 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ligand Pharmaceuticals is ranked 239.
90 Day Loss
Ligand Pharmaceuticals rank is 242
Price-to-Book
Ligand Pharmaceuticals rank is 322
Debt-to-Equity
Ligand Pharmaceuticals rank is 718
Overbought Stochastics
Ligand Pharmaceuticals rank is 1304







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.